20 min listen
E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
ratings:
Length:
20 minutes
Released:
Sep 2, 2019
Format:
Podcast episode
Description
Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD. Full reference: Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2019.04.017
Released:
Sep 2, 2019
Format:
Podcast episode
Titles in the series (77)
E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel: Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD. Full reference: Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK... by The Retina Channel Podcast